Pharma Journalist -

SMi reports: The 21st annual Superbugs & Superdrugs conference will be returning to London in just two weeks’ time. As the frequency of antibiotic resistance experiences a steady…
Read More...

The countdown begins to the highly anticipated Adaptive Designs in Clinical Trials conference in April this year. With the growing popularity in use and acceptance of adaptive…
Read More...

Nichi-Iko Pharmaceutical Co., Ltd. and Sagent Pharmaceuticals, Inc., a Nichi-Iko Group Company announced that Sagent has acquired an FDA-approved manufacturing site in Raleigh, North…
Read More...

Novo Nordisk announced publication of results from the SUSTAIN 9 Phase 3b trial in The Lancet Diabetes & Endocrinology. The objective of this 30 week trial was to assess the…
Read More...

Medexus Pharmaceuticals Inc. announced that it has entered into a licensing agreement with photonamic GmbH & Co. KG for the exclusive rights to market and distribute Gliolan in…
Read More...

Biogen announced that it has entered into an agreement to acquire Nightstar Therapeutics, a clinical-stage gene therapy company based in London, United Kingdom, which is focused on…
Read More...

Exclusive speaker interview released with Sumitomo Rubber ahead of Pre-filled Syringes West Coast 2019 In the run-up to Pre-Filled Syringes West Coast in June, SMi Group caught up…
Read More...

NantKwest and ProMab Biotechnologies announced the establishment of a worldwide license to a B-Cell Maturation Antigen (BCMA) targeted antibody sequence for multiple myeloma along with…
Read More...

SMi is delighted to present its 3rd Annual Highly Potent Active Pharmaceutical Ingredients conference, taking place in London on the 13th-14th May 2019. The global market for Highly…
Read More...

Apellis Pharmaceuticals announced a novel, risk-sharing collaboration to support the development of APL-2 in hematologic indications with SFJ Pharmaceuticals, a global drug development…
Read More...